Karamvir Yadav, Medical Oncologist at Harish Renova Hospital, shared a post on X:
“Can a pregnant patient safely receive treatment for leukemia or lymphoma?
The answer is increasingly: YES.
The 2026 JCO expert consensus highlights that many standard therapies can be delivered safely after the first trimester, while newer cellular and immune therapies remain contraindicated.
- AML/ALL – treat promptly.
- Hodgkin lymphoma – ABVD often feasible.
- Aggressive NHL – R-CHOP remains standard.
- MPNs – aspirin with interferon preferred.
- Myeloma – avoid IMiDs and anti-CD38 therapy.
A valuable practical resource for every hematologist, oncologist, and maternal-fetal medicine specialist.”
Title: Expert Opinion on the Diagnosis and Treatment of Hematologic Malignancies During Pregnancy
Authors: Daan Dierickx, Joosje H. Heimovaara, Mar Bellido, Kristel Van Calsteren, Elyce Cardonick, Alvaro Cabrera Garcia, Adinda Baten, Andrew M. Evens, Andres Ferber, Monica Fumagalli, Elzbieta Lampka, Lena Specht, Vincent Vandecaveye, Ivan R. Vogelius, Markus Alber, Frédéric Amant
Other articles featuring Karamvir Yadav on OncoDaily.